EODData

FRA, 6VX: HEALIOS K.K.

13 Oct 2026
LAST:

1.560

CHANGE:
 0.05
OPEN:
1.560
HIGH:
1.560
ASK:
0.000
VOLUME:
0
CHG(%):
3.11
PREV:
1.610
LOW:
1.560
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Oct 261.5601.5601.5601.5600
12 Oct 261.6101.6101.6101.6100
09 Oct 261.5901.5901.5901.5900
08 Oct 261.6001.6001.6001.6000
07 Oct 261.6201.6201.6201.6200
06 Oct 261.6901.6901.6901.6900
05 Oct 261.5301.5301.5301.5300
02 Oct 261.5301.5301.5301.5300
01 Oct 261.5301.5301.5301.5300
30 Sep 261.5801.5801.5801.5800

PROFILE

Name:HEALIOS K.K.
About:Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company develops HLCM051, which is preparing for phase 3 clinical trial, as well as preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is in phase 2/3 and phase 3 clinical trial to treat ischemic stroke; and HLCM051, which is in phase 2 clinical trial to treat trauma. It also develops HLCR011, which is in phase 1/2 clinical trial for the treatment of retinal pigmen epithelium and age-related macular degeneration; and HLCN061, which is in discovery and preclinical trial for treating solid tumors. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.
Sector:Healthcare
Industry:Biotechnology
Address:Hibiya Mitsui Tower, WORK STYLING, Tokyo, Japan, 100-0006
Website:https://www.healios.co.jp
ISIN:JP3835100003
LEI:3538005FFIDTDLUZOE53

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:154.00 
PEG Ratio:0.00 
Price to Sales:3.69 
Price to Book:4.19 
Profit Margin:3.51 
Operating Margin:-181.86 
Return on Assets:-0.13 
Return on Equity:0.04 
Revenue:332.5K 
Shares:115.42M 
Market Cap:180.05M 

TECHNICAL INDICATORS

MA5:1.602.3%
MA10:1.581.5%
MA20:1.560.1%
MA50:1.466.9%
MA100:1.429.9%
MA200:1.645.0%
STO9:18.75 
STO14:50.00
RSI14:48.57
WPR14:-50.00
MTM14:0.05
ROC14:0.03 
ATR:0.05 
Week High:1.698.3%
Week Low:1.560.0%
Month High:1.698.3%
Month Low:1.435.0%
Year High:2.7676.9%
Year Low:1.0548.6%